AOD-9604 vs MOTS-c vs Tesamorelin vs Semaglutide vs Tirzepatide: Mechanisms, Benefits, and Key Differences Weight loss medicine has evolved dramatically over the past decade
Week 24 Increased mental clarity, word recall, and reduced brain fog reported by many
Intramuscular Injection Some users prefer intramuscular injection, particularly when targeting specific muscle injuries
Amphetamines Cannabinoids Cocaine Opiates Phencyclidine WHAT DRUGS ARE INCLUDED IN A 6 PANEL TEST
Per injection: 2 swabs 8 weeks (once daily): ~112 swabs 12 boxes Protocol Overview A concise summary of the FDA-approved once-daily regimen
Potential benefits of using GLP-1 receptor agonists after gastric sleeve surgery include: Enhanced weight loss : Observational studies suggest post-bariatric patients using GLP-1 receptor agonists may achieve additional weight reduction, typically around 510% of body weight, though individual responses vary considerably Improved glycaemic control : Particularly beneficial for patients with type 2 diabetes or prediabetes, as GLP-1 agonists enhance insulin secretion and reduce blood glucose levels Reduced appetite : These medications can help patients who struggle with persistent hunger despite surgical intervention Cardiovascular benefits : Semaglutide has demonstrated cardiovascular risk reduction in people with established cardiovascular disease, which may benefit eligible post-bariatric patients with this specific risk profile Maintenance of weight loss : May help prevent weight regain during the critical maintenance phase Potential risks and considerations include: Gastrointestinal side effects : Nausea, vomiting, diarrhoea, and constipation are common, particularly during dose escalation
